ライフサイエンスコーパス: fellow

1 te by 5 surgeons (2 attending surgeons and 3 fellows).

2 at Stanford Medical School as a postdoctoral fellow.

3 aining as graduate students and postdoctoral fellows.

4 Pulmonary/critical care fellows.

5 ished a new follow-up clinic with cardiology fellows.

6 lem, including surveys of current and former fellows.

7 wship was sent to 19 previous RSNA Editorial Fellows.

8 d educational resources used by programs and fellows.

9 anic underrepresented minority critical care fellows.

10 ound that almost all previous RSNA Editorial Fellows (15 of 16, 94%) stayed in academic radiology, an

11 7/43; 86.0%) but residents (8/42; 18.6%) and fellows (7/43; 16.3%) were not.

12 d and consisted of 74 attending surgeons, 32 fellows, 86 residents, 19 interns, and 4 physicians with

13 eir research to their sponsors, funders, and fellow academics.

14 on the experience of being an RSNA Editorial Fellow, accomplishments achieved after the fellowship, a

15 ct as an endocrine disruptor as reported for fellow analgesics paracetamol and aspirin.

16 iption as well as image review by a research fellow and by a fellowship-trained abdominal radiologist

17 was significantly lower in MT1 eyes than in fellow and control eyes, respectively: SCP, 0.347 vs 0.5

18 LH is a PhD clinical training fellow and funded through project BuildCARE which is sup

19 ributed to completing the online modules, as fellows and faculty may have provided additional microbi

20 ecessary given the presence of residents and fellows and given a lack of agreement about necessary co

21 Pulmonary Critical Care Medicine Fellows and intensivists made a timely and accurate asse

22 h population estimates, female critical care fellows and those from racial/ethnic minorities were und

23 st study to evaluate pulmonary critical care fellows' and intensivists' use of goal-directed echocard

24 ng physicians, 9 pulmonary and critical care fellows, and 5 internal medicine residents rotating in t

25 Roles included 41.1% residents, 5.0% fellows, and 53.9% faculty.

26 graduate and graduate students, postdoctoral fellows, and senior lab visitors in my laboratory; and m

27 were interested in knowing what the previous fellows are up to presently and how their experience and

28 s at their fall 2013 retreat and to oncology fellows as part of their February 2014 in-training exami

29 how I came to know John as his postdoctoral fellow at the Laboratory of Molecular Biology in 1967 an

30 Two resident ophthalmologists and 1 glaucoma fellow at the University of Florida independently evalua

31 of Michigan in the 1950s by gastroenterology fellow Basil Hirschowitz and 2 physicists.

32 ted himself to his students, colleagues, and fellow chemists with an aura of nobility and romanticism

33 es, the occupation of similar habitats among fellow clade members apparently reduced their vulnerabil

34 ar age-related macular degeneration (AMD) or fellow control eyes, as well as analyze risk factors for

35 for surgery and good visual function in the fellow (control eye).

36 In addition, cases where the fellow cornea from the same donor had been transplanted

37 skan Native/Native Hawaiian/Pacific Islander fellows decreased from 15 (1.0%) to seven (0.3%) (p < 0.

38 Residents and fellows employed by Accreditation Council on Graduate Me

39 ine-treated eyes compared with the untreated fellow eye (+0.16 +/- 0.37 D vs -0.73 +/- 0.48 D; P < .0

40 (246 +/- 102 mum) was greater than in their fellow eye (197 +/- 86 mum; P = .023).

41 ompared with the corresponding sector in the fellow eye (58.87% vs 61.65%, respectively; P = .04).

42 eyes (85.46 +/- 8.16 mum) compared with the fellow eye (93.93 +/- 13.12 mum; P = .036).

43 (between visits variation) of the untreated fellow eye (adjusted analysis).

44 ye (AE) loses visual sensitivity whereas the fellow eye (FE) is largely unaffected.

45 als from the AE by signals from its dominant fellow eye (FE).

46 y of mesopic vision in the apparently normal fellow eye (forme fruste) to detect the earliest and mos

47 ce of AMD and accelerated progression in its fellow eye (levels 1-2: hazard ratio [HR], 4.90 [95% CI,

48 sociated with less progression of AMD in its fellow eye (levels 2-3: HR, 0.42 [95% CI, 0.33-0.55]; le

49 unaffected sector in the same eye and in the fellow eye (P < .001).

50 ssociated with the presence of a CNVM in the fellow eye (P < 0.0005; hazard ratio [HR], 2.73), and pr

51 ed significantly compared to the noninjected fellow eye (P = .01), the decrease of the RNFL was not s

52 history of SRT or retinal detachment in the fellow eye (p = 0.13).

53 otherapy (CCRT) prevented involvement of the fellow eye 1 year after symptom onset.

54 dministered 3 times daily while patching the fellow eye 2 hours daily.

55 e, progression, and regression of AMD in its fellow eye across the entire range of AMD severity.

56 one eye and forme fruste keratoconus in the fellow eye and 72normal subjects were evaluated.

57 n-patient controls included the nonimplanted fellow eye and patients' native residual vision compared

58 ked potential (FF-VEP) versus the unaffected fellow eye at baseline.

59 umab, had less severe MA than the respective fellow eye at year 7 in 88% of patients (mean area +/- s

60 20 mug) intracamerally in the study eye; the fellow eye began topical bimatoprost 0.03% once daily.

61 s for treatment included active ROP with the fellow eye being treated for type 1 ROP (2 eyes, 15.4%);

62 apy and radiotherapy, visual function in the fellow eye can be preserved.

63 ion enlargement, including both affected and fellow eye characteristics.

64 Prospective, randomized, controlled fellow eye clinical study.

65 This prospective, 9-year fellow eye comparison study suggests that an inexpensive

66 here was no significant difference in CSF of fellow eye controls (mean 1.44 +/- 0.27 %W; range 1.06-2

67 lattice degeneration in an eye in which the fellow eye had a history of RD resulted in $4414/QALY ($

68 pic eye has little effect while the stronger fellow eye has a strong effect.

69 presentation (so called unilateral KC), the fellow eye has the mildest and earliest form of the dise

70 eye and its prognostic implications for the fellow eye have focused on the incidence of neovascular

71 h 12, the difference between study eye minus fellow eye improvement in group 2 patients of 0.53 logMA

72 h 18, the difference between study eye minus fellow eye improvement in our acute group 2 gene therapy

73 An RE-PMMA IOL was implanted in the fellow eye in 46 patients (group A), and an SE-Acrylic I

74 , and an SE-Acrylic IOL was implanted in the fellow eye in 48 patients (group B).

75 regarding an increased risk of PCSON in the fellow eye in patients who have experienced it or sponta

76 ti-VEGF injection and the involvement of the fellow eye in the pathology requiring a treatment with i

77 and was thicker in the study eye compared to fellow eye in the typical AMD group (223.1 vs 208.8 mum,

78 ose who refused fellow eye surgery had lower fellow eye IOP and were more likely to have had hypotony

79 d on the incidence of neovascular AMD in the fellow eye of participants with neovascular AMD in the o

80 condary outcome was the risk of PCSON in the fellow eye of patients with prior unilateral spontaneous

81 es were AC depth in the diseased eye and the fellow eye of the same patient and the attack of ACG aft

82 seudodrusen and in eyes with late AMD in the fellow eye offer diagnostic possibilities and impact the

83 Importance: Fellow eye patching has long been the standard treatment

84 eye conveys the direction of gaze while the fellow eye points at a peripheral location in space.

85 a multivariable analysis of data, increased fellow eye preoperative intraocular pressure (IOP) was a

86 cipants; binocular group) or patching of the fellow eye prescribed for 2 hours a day (195 participant

87 r 1 hour per day (n = 40) or patching of the fellow eye prescribed for 2 hours per day (n = 60).

88 of eyes in which 1 eye received PPC and the fellow eye received FSLC.

89 s, with 1 eye receiving a manual CCC and the fellow eye receiving FSLC.

90 rs of eyes, with 1 eye receiving PPC and the fellow eye receiving manual CCC.

91 Fellow eye responses to treatment were correlated at all

92 n location, multifocality, FAF patterns, and fellow eye status.

93 main outcome measure was patient refusal of fellow eye surgery for glaucoma.

94 Those who refused fellow eye surgery had lower fellow eye IOP and were mor

95 Longer follow-up time and fellow eye surgery may reveal the significance of the su

96 Refusal of fellow eye surgery was not uncommonly encountered in the

97 t was eligible for surgery, 30 (19%) refused fellow eye surgery.

98 trabeculectomy on their study eye and had a fellow eye that was eligible for surgery, 30 (19%) refus

99 ith IOL dislocation was more likely than its fellow eye to have a diagnosis of glaucoma and to have g

100 local eye symptoms from those that underwent fellow eye trabeculectomy (all P > .05).

101 Eligible patients who refused fellow eye trabeculectomy did not differ significantly i

102 vitreal injection of 0.5 mg bevacizumab; the fellow eye underwent conventional laser photoablation.

103 Final fellow eye vision outcome was significantly correlated w

104 trabeculectomy on their study eye, and whose fellow eye was eligible for surgical treatment, were ana

105 the other parameters of the ipsilateral and fellow eye was performed using Spearman rank correlation

106 one eye and forme fruste keratoconus in the fellow eye were compared to subjects with normal eyes.

107 drusen in the study eye and late AMD in the fellow eye were enrolled.

108 iAMD in one eye and neovascular AMD in their fellow eye were imaged with FA, ICGA, and SS OCTA betwee

109 ular pressure (IOP)-lowering response in the fellow eye when using a monocular trial eliminates the n

110 The growth rate in eyes having a fellow eye with GA was higher by 0.13 mm/year (95% CI, 0

111 f the first eye was highly predictive of the fellow eye's outcome.

112 radings of both eyes, current grading of the fellow eye, and demographic data.

113 matous proliferation (RAP) lesion, GA in the fellow eye, and intraretinal fluid were associated with

114 own controls, that is, implanted eye versus fellow eye, and system on versus system off (native resi

115 ed with matched-peripapillary regions in the fellow eye, glaucoma suspect group, and normal group (al

116 Geographic atrophy in the fellow eye, hemorrhage, and absence of sub-retinal pigme

117 f subjects with study eye vision better than fellow eye, vision change from baseline to year 7, and m

118 AL were analyzed relative to treated versus fellow eye, visual outcome, and treatment modality (cont

119 Prospective, fellow eye-matched case series.

120 ge-related macular degeneration (AMD) in the fellow eye.

121 ose implant in 1 eye and sham surgery in the fellow eye.

122 uous curvilinear capsulorrhexis (CCC) in the fellow eye.

123 ions: Binocular iPad game or patching of the fellow eye.

124 ons, and compared to the patients' untreated fellow eye.

125 week 3 in the trial eye and at week 4 in the fellow eye.

126 received or refused trabeculectomy in their fellow eye.

127 24; P = 0.03) than in eyes without GA in the fellow eye.

128 severity in 1 eye tracks AMD severity in its fellow eye.

129 unilateral DME, but DME could develop in the fellow eye.

130 atrophy/fibrotic scar/neovascular AMD in the fellow eye.

131 teral with typically excellent vision in the fellow eye.

132 efect in 1 eye also had a VF defect in their fellow eye.

133 us retinal tear or retinal detachment in the fellow eye; mean number of retinal tears per eye 1.42 +/

134 sion, inactivation of only the non-deprived (fellow) eye for 10 days produced a complete restoration

135 ral corneal thickness was comparable between fellow-eye primary and secondary grafts at 3, 6, and 12

136 the scarring was 20/40 versus 20/20 for the fellow-eye primary graft.

137 n the affected eye at 6 months, adjusted for fellow-eye RNFL thickness at baseline, analysed in a mod

138 ual outcomes with secondary DMEK matched the fellow-eye visual outcomes with primary DMEK.

139 A prospective, randomized, fellow-eye-controlled clinical trial was conducted at th

140 a, multicenter, open-label, dose-escalation, fellow-eye-controlled study.

141 vel of the deep network when compared to the fellow eyes (0.519 mm(2) vs 0.410 mm(2), respectively; P

142 ively, attaining the same CSF as the control fellow eyes (1.34 +/- 0.20 %W; range 1.06-1.56 %W).

143 gnificantly shallower than in the unaffected fellow eyes (2.43 +/- 0.45 mm vs. 2.55 +/- 0.46 mm; p <

144 sity in eyes treated with IOLs compared with fellow eyes (3445 and 3487 cells/mm2, P=0.68).

145 dislocation (case group) were compared with fellow eyes (control group).

146 mm Hg in topical bimatoprost-treated pooled fellow eyes (data censored at rescue/retreatment).

147 between the primary and secondary grafts in fellow eyes (mean difference, </=2 Snellen letters; P >

148 Fellow eyes (n = 207) were treated with 5-minute dosing

149 monthly (n = 19), TREX (n = 30), and control fellow eyes (n = 39).

150 tly thicker in the study eyes as compared to fellow eyes (P < .05).

151 s present in 90% of MP eyes, but only 50% of fellow eyes (P < 0.001).

152 was -2.25 D (IQR -5.13, +0.88 D) and of the fellow eyes +1.50 D (IQR +0.88, +2.25).

153 ry readings of affected RVO eyes, unaffected fellow eyes and control eyes was not statistically diffe

154 parameters of affected BRVO eyes, unaffected fellow eyes and control eyes were statistically differen

155 rences between vascular networks, sexes, and fellow eyes and correlation between vascular density, si

156 eyes had a more anterior lens position than fellow eyes and PACS eyes, though lens thickness did not

157 y measurements were statistically similar in fellow eyes and there was no sex difference (P > .05).

158 or, nasal, and temporal RNFL compared to the fellow eyes as well as age-matched normal eyes on OCT.

159 For fellow eyes before injection, it was 56 mum, decreasing

160 itudes worsened more in treated eyes than in fellow eyes by approximately 0.05 muV (P = 0.009 exchang

161 en letters in one eye, whereas the untreated fellow eyes did not show similar improvements in visual

162 Of the 635 study and fellow eyes examined at 6 months, 134 (21%) gained and 3

163 ine the symmetry on retinal image grading of fellow eyes for retinopathy of prematurity (ROP) feature

164 ed significant variation between treated and fellow eyes from baseline to month 3 (P = .017) and mont

165 ion IOP was analyzed in study and uninjected fellow eyes from baseline to week 96.

166 Fellow eyes had a 0.09-logMAR improvement.

167 Fellow eyes had statistically similar values (P > .05).

168 tire scan was lower in BRVO eyes compared to fellow eyes in both the superficial (48.07% vs 52.60%, r

169 he ONH parameters of affected and unaffected fellow eyes in BRVO patients with those of the control e

170 7 eyes with PCV, and in 2 out of 3 enrolled fellow eyes in patients with unilateral PCV.

171 The RMS cone density difference between fellow eyes is 6.78%, and the maximum difference is 23.6

172 In 29 initially untreated fellow eyes mean SimK increased by +0.54 D (P < .02), me

173 Each eye of 37 KC patients, asymptomatic fellow eyes of 32 KC patients, and each eye of 81 normal

174 e groups, ACD was shallower in AAC eyes than fellow eyes of AAC and PACS eyes (p < 0.01 for both) and

175 types of acute angle closure and compared to fellow eyes of AAC and PACS eyes.

176 (96 patients) consisting of 71 AAC eyes, 71 fellow eyes of AAC, and 25 PACS eyes were recruited.

177 Mean differences between treated and fellow eyes of CL and IOL groups were compared with a pa

178 Clinically unaffected fellow eyes of patients with ONH showed mild features of

179 The OCT sessions for fellow eyes of unilateral retinoblastoma without any sus

180 significantly different between treated and fellow eyes preoperatively (18.1 vs. 18.7 mm, P < 0.0001

181 Exudative fellow eyes remained at risk for further vision decline

182 Fellow eyes served as controls.

183 h intravitreal injection of bevacizumab with fellow eyes treated with conventional laser photoablatio

184 f eyes with BRVO were compared with those of fellow eyes using mixed model, one-way between-groups an

185 of eyes with RVO were compared with those of fellow eyes using paired t-tests and with those of contr

186 f the superficial capillary plexus in normal fellow eyes was 12.8 +/- 1.8 mm(-1) vs 12.1 +/- 1.9 mm(-

187 nsity of the deep capillary plexus in normal fellow eyes was 17.5 +/- 1.4 mm(-1) vs 14.7 +/- 3.5 mm(-

188 The rate of GA area growth in study and fellow eyes was analyzed by linear regression of square-

189 difference in AL growth between treated and fellow eyes was not significant (3.3 vs. 3.5 mm, P = 0.3

190 Fellow eyes were eligible for enrollment because the don

191 Patients' study and fellow eyes were followed for 18 months using spectral-d

192 Fellow eyes were modeled separately.

193 ctions for the initial 2 years, during which fellow eyes were prohibited from anti-vascular endotheli

194 ross groups, and the percentage of qualified fellow eyes with a >/=2-step change was 11.4% in all AKB

195 Fellow eyes with exudative AMD had received a mean 7.3 t

196 Among fellow eyes with normal fields, progression was detected

197 Four fellow eyes with normal foveal avascular zones did not s

198 th manifest glaucoma with field loss and 192 fellow eyes without any field defect at the start of the

199 PVD in patients who chose observation and 3 fellow eyes without PVD.

200 nography and optical coherence tomography; 8 fellow eyes without PVD; and 12 control eyes: 9 eyes wit

201 Among fellow eyes without visual field loss at baseline, progr

202 eyes before treatment initiation compared to fellow eyes, allows the hypothesis that anti-VEGF treatm

203 a reduced EC count in treated compared with fellow eyes, although CCT was increased.

204 gnosed macular edema, 279 (23) microm in the fellow eyes, and 271 (38) microm in the 7 exposed eyes w

205 out from graft failure, correlations between fellow eyes, and correlations between longitudinal repea

206 s significantly better in study eyes than in fellow eyes, and MA was less severe.

207 infancy have axial growth similar to that of fellow eyes, despite having a shorter AL at the time of

208 In both APAC eyes and fellow eyes, iris curvature decreased after LPI (P < .00

209 In APAC eyes and their fellow eyes, LPI resulted in significant anterior chambe

210 In uninjected fellow eyes, only sustained IOP >21 mmHg events were hig

211 sion in study eyes (54.7 vs. 27.3 letters in fellow eyes, P < 0.001).

212 n 2.8+/-2.2 mm(2) vs. 5.8+/-2.5 mm(2) in the fellow eyes, P = 0.0013).

213 However, in fellow eyes, the increase in ACA was mainly owing to dec

214 distance (P < .01 for all) in both APAC and fellow eyes.

215 acute primary angle closure (APAC) and their fellow eyes.

216 OCTA was performed on the BRVO and fellow eyes.

217 ; P < 0.001) in operated MP eyes than normal fellow eyes.

218 d inferior/temporal (P = .6662) quadrants of fellow eyes.

219 ls to adjust for age and correlation between fellow eyes.

220 76%, P=0.002) in aphakic eyes compared with fellow eyes.

221 ers (D) to 0.63 D and differed by <0.50 D in fellow eyes.

222 Ls (605 vs. 571 mum, P<0.0001) compared with fellow eyes.

223 espectively, and in 3.3% (1/30; for both) of fellow eyes.

224 ange in cACD (P = .190) and LV (P = .430) in fellow eyes.

225 er lens vault (LV) (P = .007), compared with fellow eyes.

226 excellent" (44%), and most (55%) second-year fellows felt "fully prepared" for independent practice.

227 ACC-ITE scores from third-year fellows from 2011 to 2014 (n = 1,918) were examined.

228 Fifty-eight ophthalmology residents and fellows from a training program in Mexico consented to p

229 Eight gastroenterology fellows from one medical center were enrolled in this ES

230 representatives deciding on behalf of their fellow group members.

231 e past 16 years, the selected RSNA Editorial Fellows have learned essential processes involved in the

232 in high school and ending as a postdoctoral fellow in Professor E.B. Astwood's laboratory, when my d

233 One third (320 of 863; 37%) of fellows in Accreditation Council for Graduate Medical Ed

234 performed or partially performed by corneal fellows in training under direct supervision.

235 examination (ITE) for cardiovascular disease fellows-in-training (FITs).

236 ining experience for patients, programs, and fellows-in-training.

237 y themes of COCATS 4 from the perspective of fellows-in-training: 1) the evolution of training requir

238 Common educational resources used by fellows included UpToDate, Journal of the American Socie

239 om 2004 to 2014, the number of critical care fellows increased annually, up 54.1% from 1,606 in 2004-

240 The absolute number of black fellows increased each year but the percentage change wa

241 ogists and two interventional neuroradiology fellows, independently reviewed the CT angiography image

242 Fellows indicated interest in additional instruction in

243 Only 15% of fellows indicated they would likely be interested in can

244 cardiology attending physicians, cardiology fellows, internal medicine hospitalists, and internal me

245 peptide-encoding gene families with those of fellow legumes, Glycine max and Phaseolus vulgaris, in a

246 rating room for trainees at the resident and fellow level.

247 Top fellow-listed barriers to an academic career were diffic

248 ew of the available images, a neuroradiology fellow (M.D.M.) performed history taking and a physical

249 contributions and training of residents and fellows may also synergistically work to impress to hosp

250 Current critical care fellows may be unprepared to deal with the increasing pr

251 ed and applicable education to residents and fellows may have long-term, strategic, positive impacts

252 iation with Dixon and his other postdoctoral fellows, my independent position at Scripps, early polis

253 inician staffing included residents (n = 9), fellows (n = 4), and nurse practitioners or physician as

254 A secondary analysis examined fellows (n = 511) who took the ACC-ITE in the first and

255 as no significant difference compared to the fellow nonamblyopic eyes.

256 h only the baseline and month 18 data of the fellow (nonstudy) eyes were considered in this explorato

257 pared the projections from the amblyopic and fellow normal eye in the visual cortex.

258 iately after visits, clinicians--physicians, fellows, nurse practitioners, and physician assistants--

259 Laboratory of Molecular Biology and emeritus fellow of Wolfson College at Cambridge University, Engla

260 Twenty-one fellows participated in the study (simulation, 10; tradi

261 In conclusion, current nephrology fellows perceive several gaps in training.

262 This study assessed fellows' perceptions of current educational needs and in

263 Pulmonary Critical Care Medicine Fellows performed 154 goal-directed echocardiograms, 110

264 Pulmonary critical care fellows performed and documented their goal-directed ech

265 gly representing an intermediate between its fellow problematica Wiwaxia and Halkieria.

266 Compared with CCC in fellow rabbit eyes, PPC was equally safe and showed no g

267 electronic survey to all United States-based fellows receiving complimentary American Society of Neph

268 An ultrasound fellow recorded skin breaks, redirections, and time to c

269 In 2013, the examination was taken by 1,969 fellows, representing 194 training programs.

270 tered collaborative platform to connect with fellow researchers and discover state-of-the-art knowled

271 al with the goal of motivating and inspiring fellow researchers in the 2D materials community and the

272 Pulmonary Critical Care Medicine Fellow's area under the curve for size and function was

273 between the original report and the research fellow's assessment.

274 meliness of Pulmonary Critical Care Medicine Fellow's performance of goal-directed echocardiograms an

275 And so, my fellow scientists: ask not what you can do for reproduci

276 ditor of RadioGraphics, with the first Eyler fellow selected in 2005.

277 In novice critical care fellows, simulation-based extracorporeal membrane oxygen

278 Training directors estimated that </= 10% of fellows starting an academic career or entering private

279 year in conjunction with the ASN Nephrology Fellows Survey.

280 directors and 1,306 (80%) of 1,634 oncology fellows taking the in-training examination survey answer

281 er I moved to Harvard University as a junior fellow that my affections were captured by a seemingly m

282 through his many students and post-doctoral fellows, to whom he gave the greatest gift a scientist c

283 n (IDSA ITE) is a feedback tool used to help fellows track their knowledge acquisition during fellows

284 d other prevention educational resources for fellows, training directors, and practicing oncologists;

285 porary marriages of convenience to long-term fellow travellers.

286 eyes, but no significant change was noted in fellow unaffected eyes.

287 osmolarity between the operated eyes and the fellow unoperated control eyes at any time period during

288 pare AL growth of operated eyes with that of fellow unoperated eyes.

289 mitigated when results were adjusted to the fellow untreated eye (to the influence of between visits

290 cess predictors and to study the role of the fellow untreated eye as a co-variable for adjustment of

291 on a lack of substantial IOP effects on the fellow untreated eye, compared to brimonidine twice-dail

292 atients with neovascular AMD compared to the fellow (untreated) eye.

293 journal Radiology, several former editorial fellows were interested in knowing what the previous fel

294 The odds ratios for residents and fellows were not significantly different from attending

295 Seventeen pediatric critical care medicine fellows were recruited in 2012 and 2013 academic year.

296 ame to Scripps), and the gifted postdoctoral fellows who joined my laboratory over four decades form

297 Among the 16 previous editorial fellows who responded, there are four chairs and six vic

298 We report the findings from 16 of these fellows who responded.

299 Two Mohs surgeons and a Mohs fellow, who were blinded to the correlating gold standar

300 acterize demographic trends in critical care fellows, who represent the emerging intensivist workforc